文献速递慢病管理

考虑假性抵抗与共病后难治性高血压的患病率:爱尔兰初级保健横断面研究

Prevalence of treatment-resistant hypertension after considering pseudo-resistance and morbidity: a cross-sectional study in Irish primary care.
PubMed 文献 · Br J Gen Pract · 2018-05-08

该研究在16家全科诊所(n=50 172)中通过ATC药物搜索识别疑似难治性高血压(aTRH)患者646例,再用ABPM排除白大衣高血压、评估 dosing 充分性、依从性和共病。以140/90 mmHg为切点,aTRH患病率为9%(95%CI=9.0~10.0),进一步考虑假性抵抗后降至3%(95%CI=3.0~4.0)。结论认为逐例审查可降低TRH患病率估计,多数病例仅需处理假性抵抗。

要点

  • 全科诊所中疑似难治性高血压患病率为9%,考虑假性抵抗后降至3%。
  • 仅19%患者降压药剂量充分,84%依从用药,43%曾做过ABPM。
  • 管理TRH应逐例排查白大衣效应、剂量不足和依从性等假性抵抗因素。

核心结论

  • 逐例审查患者记录得到的TRH患病率低于既往报告,进一步考虑假性抵抗后估计值更低,多数病例可能仅需处理假性抵抗。

研究设计与样本

  • 爱尔兰初级保健横断面研究,16家全科诊所参与(n=50 172),通过ATC药物搜索识别服用降压药患者后审查个体电子病历。

主要发现

  • 646例患者存在aTRH;19%剂量充分,84%按处方续药定义依从,43%曾做过ABPM。
  • 以140/90 mmHg为切点,aTRH患病率为9%(95%CI=9.0~10.0)。
  • 进一步考虑假性抵抗后患病率降至3%(95%CI=3.0~4.0)。

关键数值与推荐

  • ABPM用于排除白大衣高血压,WHO定义的日剂量指南判定剂量充分性,依从性定义为过去一年内请求≥9次每月重复处方。
  • aTRH患病率9%(95%CI=9.0~10.0),考虑假性抵抗后3%(95%CI=3.0~4.0),血压切点140/90 mmHg。

临床怎么用

  • 全科接诊疑似难治性高血压时应先通过ABPM排除白大衣效应,并核查降压药剂量是否充分及患者依从性。
  • 逐例审查个体记录有助于避免高估TRH患病率,多数假性抵抗病例可能无需升级复杂治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To confirm treatment-resistant hypertension (TRH), ambulatory blood pressure measurement (ABPM) must exclude white-coat hypertension (WCH), three or more medications should be prescribed at the optimal doses tolerated, and non-adherence and lifestyle should be examined. Most previous studies have not adequately considered pseudo-resistance and merely provide an apparent TRH (aTRH) prevalence figure. AIM: To conduct a cross-sectional study of the prevalence of aTRH in general practice, and then consider pseudo-resistance and morbidity. DESIGN AND SETTING: With support, 16 practices ran an anatomical therapeutic chemical (ATC) drug search, identifying patients on any possible hypertensive medications, and then a search of individual patients' electronic records took place. METHOD: ABPM was used to rule out WCH. The World Health Organization-defined daily dosing guidelines determined adequate dosing. Adherence was defined as whether patients requested nine or more repeat monthly prescriptions within the past year. RESULTS: Sixteen practices participated (n = 50 172), and 646 patients had aTRH. Dosing was adequate in 19% of patients, 84% were adherent to medications, as defined by prescription refill, and 43% had ever had an ABPM. Using a BP cut-off of 140/90 mmHg, the prevalence of aTRH was 9% (95% confidence interval [CI] = 9.0 to 10.0). Consideration of pseudo-resistance further reduced prevalence rates to 3% (95% CI = 3.0 to 4.0). CONCLUSION: Reviewing individual patient records results in a lower estimate of prevalence of TRH than has been previously reported. Further consideration for individual patients of pseudo-resistance additionally lowers these estimates, and may be all that is required for management in the vast majority of cases.

来源:Br J Gen Pract,查看原文。版权归原作者所有。

引用

  1. Hayes P, Casey M, Glynn LG, et al. Prevalence of treatment-resistant hypertension after considering pseudo-resistance and morbidity: a cross-sectional study in Irish primary care. Br J Gen Pract. 2018. PMID: 29739776. doi:10.3399/bjgp18X696221

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。